Related Experiment Videos
The evolving spectrum of amiodarone hepatotoxicity
1Cornell University Medical College, New York, New York 10021.
Hepatology (Baltimore, Md.)
|July 1, 1989
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo.
British journal of pharmacology·2011
The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.
British journal of pharmacology·2011
Aspirin and aspirin-like drugs induce HLA-DR expression in HT29 colon cancer cells.
International journal of oncology·2011
The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328, MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats.
British journal of pharmacology·2010
Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer.
British journal of cancer·2008
Novel agents for cancer prevention based on nitric oxide.
Biochemical Society transactions·2007
Hepatocyte hnRNPK preserves mitochondrial integrity to restrain liver injury and fibrosis.
Hepatology (Baltimore, Md.)·2026
Liver-on-a-Chip: Applications for clinical modeling of liver disease using microscale systems.
Hepatology (Baltimore, Md.)·2026
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Hepatology (Baltimore, Md.)·2026
BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.
Blood cancer discovery·2026
Impact of GAD-65 Antibody Detection on Antihyperglycemic Therapy in T2D.
Endocrine connections·2026